Summary
None of the statements relate to Vascepa prescribing information (indications, dosage, contraindications, warnings, interactions, adverse reactions, or labeled patient population details). The provided label excerpts do not support any patient-assistance-program eligibility or coupon-card terms.
Category Scores
Accurate Statements
Unsupported Statements
The Vascepa patient assistance program has income limits.
Not supported by the provided Vascepa prescribing information excerpts; no patient assistance or coupon eligibility terms appear in the label text shown.
Applicants must have a household income below 500% of the federal poverty level.
Not supported by the provided Vascepa prescribing information excerpts; no FPL or income-threshold information is present.
500% FPL is roughly $75,000 for a single person and $150,000 for a family of four in 2024 guidelines.
Not supported by the provided Vascepa prescribing information excerpts; the label does not provide any FPL dollar amounts.
If income is above the threshold, the Vascepa patient assistance program remains closed for those above 500% FPL.
Not supported by the provided Vascepa prescribing information excerpts; no program-closure criteria are present.
Eligibility also requires a valid prescription for Vascepa.
Not supported by the provided Vascepa prescribing information excerpts; no assistance-program eligibility requirements are stated.
Eligibility requires lack of adequate insurance coverage.
Not supported by the provided Vascepa prescribing information excerpts; no insurance-coverage eligibility criteria are stated.
Eligibility requires U.S. residency.
Not supported by the provided Vascepa prescribing information excerpts; no residency eligibility criteria are stated.
Income limits do not apply to the coupon card alone.
Not supported by the provided Vascepa prescribing information excerpts; no coupon-card terms are present.
The coupon card is available to commercially insured patients.
Not supported by the provided Vascepa prescribing information excerpts; no coupon-card availability terms are present.
Contradictions
Important Omissions
If evaluating program/coupon claims, the Vascepa prescribing information excerpts provided do not contain any patient assistance program or coupon-card eligibility/terms; therefore, a label-based assessment of these claims is not possible with the supplied text.
Importance:
High
Safety Assessment
Potential Patient Risk:
High
Patient-assistance/coupon eligibility assertions are not supported by the provided FDA label excerpts. If these details are inaccurate, they could mislead patients about access to therapy or benefits, creating indirect patient harm.
Regulatory Assessment
| On Label |
No |
| Off-label Discussion |
No |
| Promotes Unapproved Use |
No |
| Hallucination Risk |
High |
Recommendation
Not Aligned
Primary Issue
Claims concern patient assistance program and coupon-card eligibility/terms, which are absent from the provided Vascepa prescribing information excerpts.
Suggested Improvement
Remove or qualify these statements as not derived from the FDA-approved prescribing information, and reference the specific official patient assistance/coupon program terms (not the prescribing label) if verification is required.